Gene · 6708
Papers1,813
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 1,813
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| RS12574989 and haplotype associated with α/β-chain imbalance and population HbA2 reduction. | BMC Med Genomics | 2022 | 35971149 | PubTator, text mining | PubMed |
| A qualitative exploration of the provision and prioritisation of smoking cessation support to patient carers in a paediatric ward in Australia. | BMC Nurs | 2022 | 35971122 | PubTator, text mining | PubMed |
| Detection of erythroid progenitors and erythrocytopathies in patients with severe COVID-19 disease. | Saudi Med J | 2022 | 35964959 | PubTator, text mining | PubMed |
| Comprehensive genomic profiling of Finnish lung adenocarcinoma cohort reveals high clinical actionability and SMARCA4 altered tumors with variable histology and poor prognosis. | Neoplasia | 2022 | 35964518 | PubTator, text mining | PubMed |
| Unravelling the genetic and phenotypic heterogeneity of SPTA1 gene variants in Hereditary Elliptocytosis and Hereditary Pyropoikilocytosis patients using next-generation sequencing. | Gene | 2022 | 35961434 | PubTator, text mining | PubMed |
| Integrated analysis reveals prognostic value and progression-related role of AMIGO2 in prostate cancer. | Transl Androl Urol | 2022 | 35958903 | PubTator, text mining | PubMed |
| Multidimensional difference analysis in gastric cancer patients between high and low latitude. | Front Genet | 2022 | 35957688 | PubTator, text mining | PubMed |
| A Novel Antibody Targeting the Second Extracellular Loop of the Serotonin 5-HT2A Receptor Inhibits Platelet Function. | Int J Mol Sci | 2022 | 35955928 | PubTator, text mining | PubMed |
| Evaluation of a Patient With Non-Myoinvasive Uterine Serous Carcinoma Confined to a Polyp and Positive Peritoneal Washings With Somatic ARHGAP35 and KRAS Mutations. | Cureus | 2022 | 35949786 | PubTator, text mining | PubMed |
| PTCH1 mutant small cell glioblastoma in a patient with Gorlin syndrome: A case report. | Oncol Lett | 2022 | 35949590 | PubTator, text mining | PubMed |
| Novel SPTB frameshift mutation in a Chinese neonatal case of hereditary spherocytosis type 2: A case report. | Exp Ther Med | 2022 | 35949318 | PubTator, text mining | PubMed |
| Identification of pyroptosis-related subtypes, development of a prognostic model, and characterization of tumour microenvironment infiltration in gastric cancer. | Front Genet | 2022 | 35923703 | PubTator, text mining | PubMed |
| Functional modulation of PTH1R activation and signaling by RAMP2. | Proc Natl Acad Sci U S A | 2022 | 35914163 | PubTator, text mining | PubMed |
| Metabolic Rewiring in Glioblastoma Cancer: EGFR, IDH and Beyond. | Front Oncol | 2022 | 35912242 | PubTator, text mining | PubMed |
| Genomic Features of Organ-Specific Metastases in Lung Adenocarcinoma. | Front Oncol | 2022 | 35912232 | PubTator, text mining | PubMed |
| NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer. | Front Immunol | 2022 | 35911687 | PubTator, text mining | PubMed |
| Molecular Landscape of ERBB2 Alterations in 14,956 Solid Tumors. | Pathol Oncol Res | 2022 | 35911441 | PubTator, text mining | PubMed |
| Analysis of Binding Determinants for Different Classes of Competitive and Noncompetitive Inhibitors of Glycine Transporters. | Int J Mol Sci | 2022 | 35887394 | PubTator, text mining | PubMed |
| Structure Prediction, Evaluation, and Validation of GPR18 Lipid Receptor Using Free Programs. | Int J Mol Sci | 2022 | 35887268 | PubTator, text mining | PubMed |
| TP53 and LRP1B Co-Wild Predicts Improved Survival for Patients with LUSC Receiving Anti-PD-L1 Immunotherapy. | Cancers (Basel) | 2022 | 35884443 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6708/papers?page=19